Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 First Quarter Earnings Conference Call on Tuesday, November 11, 2008 at 8:3...( CHENGDU China Nov. 6 /Xinhua-- Ti...),Health
Navigation Links
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 First Quarter Earnings Conference Call on Tuesday, November 11, 2008 at 8:30 a.m. EST
Date:11/6/2008
CHENGDU, China, Nov. 6 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that management will hold a conference call to discuss its 2009 fiscal first quarter at 8:30 a.m. EST on Tuesday, November 11, 2008. Financial results will be released that day before the market opens.
Interested parties may access the call by dialing 800-762-8795 from within the United States, or 480-629-9031 if calling internationally. The conference ID is 3940851. It is advisable to dial in approximately 5-10 minutes prior to the start of the call. A replay will be available through November 27, 2008 and can be accessed by dialing 800-406-7325 (U.S.), 303-590-3030 (Int'l), passcode 3940851.
This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00005918 . To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp .
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and supplier of modernized Traditional
Chinese Medicine ("TCM") in China. It was established in 1994 and acquired
by the current management team in August 2003. It has a comprehensive
product portfolio of 33 modernized TCMs and 5 generic wester
'/>"/>
| SOURCE Tianyin Pharmaceutical, Co., Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
5. Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
6. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
7. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
8. Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction
9. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
10. Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program
11. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
Post Your Comments:
Breaking Medicine News(10 mins):Health News:The Concord Grape Commands Attention at Major Scientific Conference 2Health News:The Concord Grape Commands Attention at Major Scientific Conference 3Health News:The Concord Grape Commands Attention at Major Scientific Conference 4Health News:The Concord Grape Commands Attention at Major Scientific Conference 5Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2Health News:Hoag Hospital Named One of the Nation's Top Cardiovascular Hospitals by Thomson Reuters 2Health News:Hoag Hospital Named One of the Nation's Top Cardiovascular Hospitals by Thomson Reuters 3Health News:A new target for lymphoma therapy 2
[1] The Concord Grape Commands Attention at Major Scientific Conference[0] Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010[0] Hoag Hospital Named One of the Nation's Top Cardiovascular Hospitals by Thomson Reuters[0] A new target for lymphoma therapy[0] Jefferson awarded multi-million dollar NIH grant
Other Medicine News:Health News:Leading IVF Practice to Open 11th New England Location 2Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 2Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 3Health News:Cost of Massachusetts Health Insurance Mandate to Rise 85% -- $400 Mil -- in '09; CA Mandate Proposal Certain to Face Similar Increases 2Health News:U.S. Department of Labor Announces $1.25 Million to North Carolina to Help Trade-Affected Workers Pay for Health Insurance 2Health News:Surprise in Lab Helps ID Drug to Fight ALS 2
Leading IVF Practice to Open 11th New England LocationJustice Department Requires Divestitures in Pearson's Acquisition of Harcourt AssessmentCost of Massachusetts Health Insurance Mandate to Rise 85% -- $400 Mil -- in '09; CA Mandate Proposal Certain to Face Similar IncreasesU.S. Department of Labor Announces $1.25 Million to North Carolina to Help Trade-Affected Workers Pay for Health InsuranceSurprise in Lab Helps ID Drug to Fight ALS United American Healthcare Corporation To Host Fiscal 2008 Second Quarter Results Conference Call Feb. 7
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Beverage Can Tabs Remain a Risk for Kids 62236 1Beverage Can Tabs Remain a Risk for Kids 62236 2Health Reform 3A Whats in It for You 3F 62234 1Health Reform 3A Whats in It for You 3F 62234 2Health Reform 3A Whats in It for You 3F 62234 3APR Energy Donates Medicine and Medical Services to Community of La Esperanza 62232 1APR Energy Donates Medicine and Medical Services to Community of La Esperanza 62232 2
Other Medicine Technology:Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |